A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates (Q40255696)

18 September 2017

A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates (English)

1 reference

18 September 2017

0 references

Hsin-Wei Chen

1

1 reference

18 September 2017

Shih-Jen Liu

2

1 reference

18 September 2017

Yi-Shiuan Li

3

1 reference

18 September 2017

Hsueh-Hung Liu

4

1 reference

18 September 2017

Jy-Ping Tsai

5

1 reference

18 September 2017

Chen-Yi Chiang

6

1 reference

18 September 2017

Mei-Yu Chen

7

1 reference

18 September 2017

Chyi-Sing Hwang

8

1 reference

18 September 2017

Chin-Cheng Huang

9

1 reference

18 September 2017

Hui-Mei Hu

10

1 reference

18 September 2017

Han-Hsuan Chung

11

1 reference

18 September 2017

Sze-Hsien Wu

12

1 reference

18 September 2017

Pele Chong

13

1 reference

18 September 2017

Chih-Hsiang Leng

14

1 reference

18 September 2017

Chien-Hsiung Pan

15

1 reference

18 September 2017

1 March 2013

1 reference

18 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Archives of Virology

1 reference

18 September 2017

158

1 reference

18 September 2017

7

1 reference

18 September 2017

1523-1531

1 reference

https://scigraph.springernature.com/pub.10.1007/s00705-013-1639-1

18 September 2017

0 references

cites work

NS5 of dengue virus mediates STAT2 binding and degradation

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Flavivirus genome organization, expression, and replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

A novel single-dose dengue subunit vaccine induces memory immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Dengue: a continuing global threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Global spread and persistence of dengue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

The mannose receptor mediates dengue virus infection of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Structure of the dengue virus envelope protein after membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Antibody-dependent enhancement of infection and the pathogenesis of viral disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Induction of protective antibodies against dengue virus by tetravalent DNA immunization of mice with domain III of the envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

A structural perspective of the flavivirus life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Protective Mechanisms Induced by a Japanese Encephalitis Virus DNA Vaccine: Requirement for Antibody but Not CD8+ Cytotoxic T-Cell Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Dose-dependent protection against or exacerbation of disease by a polylactide glycolide microparticle-adsorbed, alphavirus-based measles virus DNA vaccine in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1639-1

10.1007/S00705-013-1639-1

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference